Taiho Oncology CEO Tim Whitten: Building Upon Lonsurf, Inqovi

 
• By Joseph Haas

Solid tumor-focused Taiho Oncology teams with hematological cancer specialist Astex under the Otsuka umbrella. Taiho also performs US/Canada commercialization for all three firms.

Drug_Design
Otsuka affiliate Taiho has high expectations for its cholangiocarcinoma drug

More from Strategy

More from Business